OppenheimerFunds’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-54,408
| Closed | -$3.03M | – | 1856 |
|
|
2018
Q4 | $3.03M | Buy |
+54,408
| New | +$2.95M | ﹤0.01% | 802 |
|
|
2016
Q4 | – | Sell |
-215,595
| Closed | -$11.6M | – | 1829 |
|
|
2016
Q3 | $11.6M | Sell |
215,595
-196,673
| -48% | -$9.13M | 0.01% | 704 |
|
|
2016
Q2 | $17.7M | Sell |
412,268
-251,877
| -38% | -$10.6M | 0.02% | 588 |
|
|
2016
Q1 | $33.5M | Buy |
664,145
+37,378
| +6% | +$1.8M | 0.04% | 411 |
|
|
2015
Q4 | $39.7M | Buy |
626,767
+146,412
| +30% | +$9.97M | 0.05% | 384 |
|
|
2015
Q3 | $31.5M | Buy |
480,355
+12,388
| +3% | +$822K | 0.04% | 432 |
|
|
2015
Q2 | $31.7M | Sell |
467,967
-183,991
| -28% | -$10.2M | 0.04% | 469 |
|
|
2015
Q1 | $27.8M | Sell |
651,958
-25,683
| -4% | -$1.14M | 0.03% | 511 |
|
|
2014
Q4 | $33.5M | Buy |
677,641
+129,892
| +24% | +$5.2M | 0.04% | 469 |
|
|
2014
Q3 | $15.7M | Buy |
547,749
+300,804
| +122% | +$8.17M | 0.02% | 624 |
|
|
2014
Q2 | $6.46M | Sell |
246,945
-659,319
| -73% | -$17M | 0.01% | 820 |
|
|
2014
Q1 | $50.5M | Buy |
906,264
+181,001
| +25% | +$10.4M | 0.06% | 334 |
|
|
2013
Q4 | $34.9M | Sell |
725,263
-38,333
| -5% | -$1.61M | 0.04% | 425 |
|
|
2013
Q3 | $32.1M | Sell |
763,596
-23,660
| -3% | -$1.13M | 0.04% | 418 |
|
|
2013
Q2 | $35.5M | Buy |
+787,256
| New | +$30.9M | 0.05% | 393 |
|
OppenheimerFunds's IMPV Position: Q1 2019 in Review
OppenheimerFunds sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 54,408 shares — an estimated $3.03M sold.
OppenheimerFunds first reported a position in IMPV in Q2 2013 and held it in 15 quarters. The position peaked at $50.5M in Q1 2014. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- OppenheimerFunds reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- OppenheimerFunds sold 54,408 Imperva, Inc. shares in Q1 2019, an estimated $3.03M.
- OppenheimerFunds first reported a position in Imperva, Inc. in Q2 2013 and held it in 15 quarters.
- OppenheimerFunds's Imperva, Inc. position peaked at $50.5M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.